Glaxosmithkline Pharmaceuticals fundamental analysis

GLAXO

2487

32.20 (-1.28%)
Last updated on 10 Mar, 2026 | 15:56 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Glaxosmithkline Pharmaceuticals Fundamentals

P/E Ratio

41.84

P/B Ratio

21.32

Div. Yield

2.14

Sector P/E

60.42

Sector P/B

2.64

Sec. Div. Yield

0.58

Glaxosmithkline Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 41.84, compared to the sector average of 60.42. Its P/B Ratio stands at 21.32, while the sector’s is 2.64. In terms of returns, the stock offers a Dividend Yield of 2.14%, which is than the sector’s 0.58%.

Glaxosmithkline Pharmaceuticals Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Glaxosmithkline Pharmaceuticals reflects: Price – Attractive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost